70.94
Nutrien Ltd stock is traded at $70.94, with a volume of 1.87M.
It is down -0.49% in the last 24 hours and down -3.64% over the past month.
Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.
See More
Previous Close:
$71.29
Open:
$71.15
24h Volume:
1.87M
Relative Volume:
0.53
Market Cap:
$34.05B
Revenue:
$27.83B
Net Income/Loss:
$2.42B
P/E Ratio:
14.44
EPS:
4.9113
Net Cash Flow:
$2.21B
1W Performance:
+3.74%
1M Performance:
-3.64%
6M Performance:
+19.49%
1Y Performance:
+24.50%
Nutrien Ltd Stock (NTR) Company Profile
Compare NTR vs CTVA, CF, ICL, MOS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NTR
Nutrien Ltd
|
70.94 | 34.22B | 27.83B | 2.42B | 2.21B | 4.9113 |
|
CTVA
Corteva Inc
|
83.30 | 55.75B | 17.89B | 1.26B | 2.05B | 1.7029 |
|
CF
Cf Industries Holdings Inc
|
122.97 | 19.28B | 7.41B | 2.12B | 1.62B | 11.13 |
|
ICL
Icl Group Ltd
|
6.57 | 8.80B | 7.15B | 280.00M | 137.88M | 0.1749 |
|
MOS
Mosaic Company
|
22.68 | 7.24B | 12.05B | 575.40M | -534.60M | 1.6871 |
Nutrien Ltd Stock (NTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-26-26 | Downgrade | UBS | Neutral → Sell |
| Mar-13-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-12-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-23-26 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Jan-14-26 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-14-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-05-25 | Initiated | National Bank Financial | Sector Perform |
| Jul-11-25 | Downgrade | Jefferies | Buy → Hold |
| Jun-17-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-14-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-13-25 | Initiated | Goldman | Sell |
| Jan-21-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-13-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-13-25 | Upgrade | Piper Sandler | Underweight → Overweight |
| Dec-03-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-10-24 | Downgrade | UBS | Buy → Neutral |
| Sep-24-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-10-24 | Downgrade | Goldman | Buy → Neutral |
| Aug-02-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Apr-29-24 | Upgrade | Berenberg | Hold → Buy |
| Mar-26-24 | Initiated | Jefferies | Buy |
| Mar-01-24 | Initiated | Wolfe Research | Outperform |
| Feb-29-24 | Downgrade | Piper Sandler | Neutral → Underweight |
| Feb-23-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-12-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-30-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Nov-14-23 | Upgrade | Barclays | Underweight → Overweight |
| Nov-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-14-23 | Downgrade | Barclays | Overweight → Underweight |
| Jul-31-23 | Upgrade | TD Securities | Hold → Buy |
| Jul-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-17-23 | Downgrade | Berenberg | Buy → Hold |
| May-12-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-08-23 | Downgrade | TD Securities | Buy → Hold |
| Feb-03-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-19-23 | Initiated | Wells Fargo | Equal Weight |
| Jan-09-23 | Resumed | Credit Suisse | Underperform |
| Nov-30-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-03-22 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Oct-21-22 | Downgrade | HSBC Securities | Buy → Hold |
| Aug-09-22 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-14-22 | Initiated | Credit Suisse | Underperform |
| Jun-01-22 | Initiated | Barclays | Overweight |
| Mar-28-22 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-18-22 | Upgrade | Atlantic Equities | Underweight → Neutral |
| Dec-17-21 | Initiated | Piper Sandler | Neutral |
| Oct-13-21 | Initiated | Mizuho | Neutral |
| Sep-14-21 | Reiterated | BofA Securities | Buy |
| Jun-29-21 | Upgrade | Susquehanna | Neutral → Positive |
| Jun-15-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| May-24-21 | Upgrade | HSBC Securities | Hold → Buy |
| Feb-23-21 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-12-21 | Downgrade | Atlantic Equities | Neutral → Underweight |
| Dec-03-20 | Downgrade | Susquehanna | Positive → Neutral |
| Aug-25-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
| May-14-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| May-11-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Apr-09-20 | Upgrade | Citigroup | Neutral → Buy |
| Mar-26-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-02-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-27-20 | Upgrade | Berenberg | Hold → Buy |
| Feb-14-20 | Downgrade | Citigroup | Buy → Neutral |
| Feb-10-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Jan-23-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-15-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Nov-25-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Sep-23-19 | Initiated | Consumer Edge Research | Overweight |
| Aug-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Apr-23-19 | Reiterated | Cowen | Outperform |
| Mar-06-19 | Reiterated | Cowen | Outperform |
| Dec-13-18 | Initiated | JP Morgan | Neutral |
View All
Nutrien Ltd Stock (NTR) Latest News
Specialty Fertilizers Market is expected to Hit US$ 110.4 - openPR.com
Nutrien Ltd. 2026 Q1ResultsEarnings Call Presentation (TSX:NTR:CA) 2026-05-13 - Seeking Alpha
Nutrien Ltd at BMO Capital Markets Global Farm to Market Conference Transcript - GuruFocus
Nutrien Ltd. stock falls Wednesday, underperforms market - MarketWatch
BASF and Nutrien Collaborate on Expanding Farmer Access to Biofuel Markets - renewableenergymagazine.com
Nutrien Q1 Earnings Call Highlights - Yahoo Finance
Nutrien Ltd (NTR) Shares Surge 5.3% -- What GF Score of 71 Tells Investors - GuruFocus
Nutrien’s Portfolio Shift Gains Attention On The TSX Composite Index - Kalkine Media
Nutrien Ltd. stock rises Tuesday, outperforms market - MarketWatch
Is Nutrien (TSX:NTR) Quietly Rebuilding Its Portfolio Around Higher‑Quality, Cash‑Generative Assets? - simplywall.st
NTR Maintained by Oppenheimer -- Price Target Raised to $82.00 - GuruFocus
Oppenheimer Adjusts Price Target on Nutrien to $82 From $80, Maintains Outperform Rating - marketscreener.com
NTR.CA Technical Analysis | Trend, Signals & Chart Patterns | NUTRIEN LTD (TSX:NTR) - ChartMill
Is Nutrien Ltd (NTR) Overvalued After 4.3% Rally? GF Value Says - GuruFocus
NTR Maintained by UBS -- Price Target Lowered to $65.00 - GuruFocus
Nutrien Ltd. stock rises Monday, outperforms market - MarketWatch
NTR Maintained by JP Morgan -- Price Target Raised to $80 - GuruFocus
Nutrien Supported by Strong Execution, Fertilizer Fundamentals, RBC Says - marketscreener.com
NTR Maintained by Scotiabank -- Price Target Raised to $80 - GuruFocus
Nutrien Ltd. Price Target Cut to C$83.00/Share From C$86.00 by TD - Moomoo
Nutrien Ltd. Is Maintained at Buy by TD - Moomoo
BASF and Nutrien collaborate on expanding farmer access to low-carbon biofuel markets - High Plains Journal
UBS Adjusts Price Target on Nutrien to $65 From $67, Maintains Sell Rating - marketscreener.com
Keith Martell Bought 35% More Shares In Nutrien - simplywall.st
Insider Spends US$142k Buying More Shares In Nutrien - Yahoo Finance
NUTRIEN : JP Morgan remains its Buy rating - marketscreener.com
NUTRIEN : JP Morgan maintains a Buy rating - marketscreener.com
Nutrien: Fertilizer Demand Isn't Going Anywhere, And The Market Is Undervaluing It - Seeking Alpha
NTR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Nutrien considering sale of facility, says memo to staff - Trinidad Guardian
Is Nutrien (TSX:NTR) Now Attractive After Recent Share Price Pullback? - simplywall.st
Nutrien Ltd. stock rises Friday, still underperforms market - MarketWatch
Is Nutrien (TSX:NTR) Tracking TSX Materials Momentum Shift? - Kalkine Media
NUTRIEN : RBC maintains a Buy rating - marketscreener.com
Is It Too Late To Consider Nutrien (TSX:NTR) After Its Recent Share Price Surge? - Yahoo Finance
Fertilizer Firms See Profit Windfall as War Upends Supplies - Insurance Journal
Mark Thompson to Speak at BMO Farm to Market Conference - geneonline.com
Nutrien Announces Mark Thompson as a Speaker at the BMO Farm to Market Conference - The Globe and Mail
Jefferies: Nutrien Q1 earnings beat estimates as fertilizer market stays tight - Investing.com Australia
Nutrien Ltd. Reportedly Explores Strategic Alternatives for Trinidad Nitrogen Facility - marketscreener.com
Nutrien Q1 Earnings Beat Estimates on Record Potash Volumes - Yahoo Finance
Research Alert: CFRA Maintains Sell Rating On Shares Of Nutrien - 富途牛牛
Nutrien Shareholders Back Board, Auditor and Pay Plan at 2026 AGM - The Globe and Mail
Nutrien signals stabilisation in volatile fertiliser markets as retail arm cushions shocks - AgTechNavigator.com
NTR Stock Chart | NUTRIEN LTD (NYSE:NTR) - ChartMill
Nutrien Should See Higher Near-Term Profits as Middle East Supply Shock Boosts Fertilizer Prices - Morningstar
International Value Portfolio's Nutrien Ltd(NTR) Holding History - GuruFocus
Nutrien Q1 2026 slides: record potash volumes, stock tumbles 7% By Investing.com - Investing.com Canada
Nutrien (TSX:NTR) Q1 EPS Outcome Tests Bullish Margin Improvement Narrative - simplywall.st
Nutrien Q1 2026 slides: record potash volumes, stock tumbles 7% - Investing.com
Nutrien Earnings: Shares Fall as Middle East Conflict Resolution Will Alleviate Supply Shock - Morningstar Canada
Nutrien Ltd Stock (NTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):